Page last updated: 2024-08-17

thymidine and cetrorelix

thymidine has been researched along with cetrorelix in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pinski, J; Radulovic, S; Schally, AV; Yano, T	1
Cai, RZ; Galvan, G; Groot, K; Halmos, G; Jungwirth, A; Pinski, J; Schally, AV; Szepeshazi, K	1

Other Studies

2 other study(ies) available for thymidine and cetrorelix

Article	Year
Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America, 1994, Mar-01, Volume: 91, Issue:5 Topics: Cell Division; Cystadenocarcinoma, Papillary; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Kinetics; Ovarian Neoplasms; Receptors, LHRH; Thymidine; Triptorelin Pamoate; Tumor Cells, Cultured	1994
Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. The Prostate, 1997, Aug-01, Volume: 32, Issue:3 Topics: Animals; Antineoplastic Agents; Bombesin; Cell Division; DNA, Neoplasm; Drug Combinations; ErbB Receptors; Gastrins; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Luteinizing Hormone; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Prostate; Prostatic Neoplasms; Receptors, Bombesin; Testosterone; Thymidine; Tumor Cells, Cultured	1997

Article

Year

Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.

Proceedings of the National Academy of Sciences of the United States of America, 1994, Mar-01, Volume: 91, Issue:5

Topics: Cell Division; Cystadenocarcinoma, Papillary; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Kinetics; Ovarian Neoplasms; Receptors, LHRH; Thymidine; Triptorelin Pamoate; Tumor Cells, Cultured

1994

Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice.

The Prostate, 1997, Aug-01, Volume: 32, Issue:3

Topics: Animals; Antineoplastic Agents; Bombesin; Cell Division; DNA, Neoplasm; Drug Combinations; ErbB Receptors; Gastrins; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Luteinizing Hormone; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptide Fragments; Prostate; Prostatic Neoplasms; Receptors, Bombesin; Testosterone; Thymidine; Tumor Cells, Cultured

1997